Insider Trading March 13, 2026

B&G Foods President Disposes of 20,000 Shares as Company Navigates Portfolio Shift

Transaction by Andrew D. Vogel coincides with Q4 2025 results, Green Giant sale and planned College Inn/KB acquisition

By Priya Menon BGS
B&G Foods President Disposes of 20,000 Shares as Company Navigates Portfolio Shift
BGS

Andrew D. Vogel, executive vice president and president of meals at B&G Foods, sold 20,000 shares on March 13, 2026, receiving $103,762. The insider transaction occurs amid B&G Foods' mixed fourth-quarter 2025 results, an announced divestiture of the Green Giant frozen business, and plans to acquire College Inn/KB. Multiple analysts adjusted price targets following the developments.

Key Points

  • Andrew D. Vogel sold 20,000 shares on March 13, 2026, for $103,762 at a weighted average price of $5.1881.
  • B&G Foods reported Q4 2025 adjusted EPS of $0.28, below the $0.30 forecast, while revenue was $539.6 million versus an expected $538 million.
  • Company announced divestiture of Green Giant frozen business and plans to acquire College Inn/KB; several analysts raised price targets.

Andrew D. Vogel, who serves as executive vice president and president of meals at B&G Foods, Inc. (NYSE: BGS), completed sales of 20,000 shares of the company’s common stock on March 13, 2026. The total proceeds from the transaction were $103,762, with trades executed across a price range of $5.1700 to $5.2150 per share and a weighted average sale price of $5.1881.

After these dispositions, Vogel retains direct ownership of 50,679 shares of B&G Foods. The move is recorded alongside a series of corporate developments that have attracted analyst attention.

In its fourth-quarter 2025 report, B&G Foods posted adjusted earnings per share of $0.28, which fell short of the $0.30 forecast. The company did, however, top revenue expectations by reporting $539.6 million versus the $538 million that had been anticipated.

Separately, management announced a strategic divestiture of its Green Giant frozen business and stated plans to acquire College Inn/KB. Those portfolio actions have prompted analysts to revisit their valuation assumptions and price targets for the stock.

Analyst adjustments include a raise by Jefferies to a $5.00 price target from $4.00, which the firm attributed to stabilization in the company’s fourth-quarter performance. TD Cowen increased its target to $4.00 from $3.50, citing the company’s portfolio reshaping. Evercore ISI raised its target to $5.00 from $4.50 and projected a 3% year-over-year increase in 2026 EBITDA to $281 million, a figure the firm expects to exceed consensus.

Taken together, the insider sale, the mixed earnings print, and the announced divestiture and acquisition plans mark a period of active transition for B&G Foods. Analysts have reacted by adjusting their targets, reflecting the company’s recent operational and portfolio developments.


Summary

Vogel sold 20,000 shares for $103,762 on March 13, 2026, at an average of $5.1881 per share and retains 50,679 shares. B&G Foods reported Q4 2025 adjusted EPS of $0.28 on revenue of $539.6 million. The company announced a divestiture of the Green Giant frozen business and plans to acquire College Inn/KB. Several analysts raised price targets following these developments.

Key points

  • Insider transaction - Andrew D. Vogel sold 20,000 shares on March 13, 2026, for $103,762 at a weighted average price of $5.1881.
  • Financial results - B&G Foods reported Q4 2025 adjusted EPS of $0.28 versus a $0.30 forecast and revenue of $539.6 million versus an expected $538 million.
  • Portfolio moves and analyst response - The company plans to divest the Green Giant frozen business and acquire College Inn/KB, prompting several price-target increases from Jefferies, TD Cowen, and Evercore ISI.

Risks and uncertainties

  • Earnings shortfall - Adjusted EPS for Q4 2025 was below consensus, introducing uncertainty about near-term profit performance for stakeholders in the consumer packaged foods sector.
  • Portfolio execution - The planned divestiture of the Green Giant frozen business and the acquisition of College Inn/KB create execution risk around integration, timing, and expected benefits for the company and its suppliers.
  • Analyst expectations - While several firms raised price targets, these adjustments reflect evolving assumptions; changes in operational or market conditions could alter those outlooks and affect investor sentiment in the food manufacturing and consumer staples sectors.

Risks

  • Adjusted EPS missed the forecast, creating uncertainty about short-term profitability in the consumer packaged foods sector.
  • Execution risk tied to the divestiture of Green Giant frozen business and the planned acquisition of College Inn/KB could affect operations and integration.
  • Revised analyst price targets reflect changing assumptions; further operational or market shifts could alter investor expectations for the stock.

More from Insider Trading

Framework Ventures Increases Stake in Better Home & Finance with $1.006M Purchase Mar 13, 2026 Ligand CFO Sells $687,825 in Stock, Exercises Options as Shares Trade Near Yearly High Mar 13, 2026 Alignment Healthcare President Executes $507,925 Stock Sale to Cover RSU Taxes Mar 13, 2026 Alignment Healthcare CIO Sells Shares to Cover RSU Taxes; Company Faces Mixed Market Signals Mar 13, 2026 Alignment Healthcare CEO Sells $853,125 in Stock to Cover RSU Withholding Mar 13, 2026